Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts
Open accessThe DOI matches its Crossref record.
Abstract
OBJECTIVE: The protein phosphatase inhibitor-1 (I-1) is a highly specific and potent inhibitor of type 1 phosphatases (PP1) that is active only in its protein kinase A (PKA)-phosphorylated form. I-1 ablation decreases, I-1 overexpression sensitizes beta-adrenergic signaling in the heart. It is controversial whether I-1 expression is altered in human heart failure (HF), likely because its detection in heart is difficult due to its low abundance. METHODS AND RESULTS: I-1 was >500-fold enriched from left ventricular myocardium (LVM) from patients with terminal HF (n=16) and non-failing controls (NF, n=5) and quantified with an affinity-purified I-1 and a I-1 phosphospecific antiserum. In non-failing I-1 protein levels amounted to 126 fmol/mg protein. In failing hearts, I-1 protein levels were reduced by 58% and I-1 phosphorylation by 77% (P<0.001 vs. NF). I-1 phosphorylation correlated well with serine-16 phosphorylation of phospholamban (PLB) in the same hearts (P<0.001). In contrast, PLB, troponin I (TnI) and PP1 protein and TnI phosphorylation levels did not differ between HF and NF. CONCLUSIONS: The results suggest that the reduction in I-1 protein and phosphorylation in failing human hearts leads to increased phosphatase activity which in turn may result in reduced phosphorylation of cardiac proteins such as PLB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Regulation of cardiac contractile function by troponin I phosphorylation
LAYLAND, J., SOLARO, R., & SHAH, A. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.022 · Cited by 385
“Several studies have reported a significant reduction in basal cTnI-phosphorylation at PKA sites (Ser23/24) in human heart failure [6–8] although this is not a universal finding [73,76].”
BackgroundMolecular Determinants of Altered Ca 2+ Handling in Human Chronic Atrial Fibrillation
El-Armouche, A., Boknik, P., Eschenhagen, T., Carrier, L., Knaut, M., Ravens, U., & Dobrev, D. (2006) · Circulation · doi:10.1161/circulationaha.106.636845 · Cited by 274
Self-citationPeriasamy, M., Bhupathy, P., & Babu, G. J. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm056 · Cited by 259
Sossalla, S., Fluschnik, N., Schotola, H., Ort, K. R., Neef, S., Schulte, T., Wittköpper, K., Renner, A., Schmitto, J. D., Gummert, J., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.220418 · Cited by 237
Self-citationMesser, A. E., Gallon, C. E., McKenna, W. J., Dos Remedios, C. G., & Marston, S. B. (2009) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.200900071 · Cited by 61
“On the other hand, non-specific reduction in phosphorylation is compatible with reports of increased phosphatase activity in failing heart, which may itself be a consequence of enhanced PKC activity [4, 41–44].”
Background
Metadata
- Authors
- El-Armouche, A.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 61
- Issue
- 1
- Pages
- 87-93
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W1978578637
- Cited by
- 141
- References
- 0
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. https://app.cochat.ai/papers/10.1016/j.cardiores.2003.11.005
- The paper
- El-Armouche, A. (2004). Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovascular Research. https://doi.org/10.1016/j.cardiores.2003.11.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.